vs

Side-by-side financial comparison of CME Group (CME) and SANMINA CORP (SANM). Click either name above to swap in a different company.

SANMINA CORP is the larger business by last-quarter revenue ($3.2B vs $1.9B, roughly 1.7× CME Group). SANMINA CORP runs the higher net margin — 1.5% vs 0.1%, a 1.5% gap on every dollar of revenue. On growth, SANMINA CORP posted the faster year-over-year revenue change (59.0% vs 14.5%). Over the past eight quarters, SANMINA CORP's revenue compounded faster (31.9% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Sanmina Corporation is an American electronics manufacturing services (EMS) provider headquartered in San Jose, California that serves original equipment manufacturers (OEMs) in communications and computer hardware fields. The firm has nearly 80 manufacturing sites, and is one of the world’s largest independent manufacturers of printed circuit boards and backplanes. As of 2022, it is ranked number 482 in the Fortune 500 list.

CME vs SANM — Head-to-Head

Bigger by revenue
SANM
SANM
1.7× larger
SANM
$3.2B
$1.9B
CME
Growing faster (revenue YoY)
SANM
SANM
+44.5% gap
SANM
59.0%
14.5%
CME
Higher net margin
SANM
SANM
1.5% more per $
SANM
1.5%
0.1%
CME
Faster 2-yr revenue CAGR
SANM
SANM
Annualised
SANM
31.9%
10.8%
CME

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CME
CME
SANM
SANM
Revenue
$1.9B
$3.2B
Net Profit
$1.2M
$49.3M
Gross Margin
7.6%
Operating Margin
0.1%
2.3%
Net Margin
0.1%
1.5%
Revenue YoY
14.5%
59.0%
Net Profit YoY
20.7%
-24.2%
EPS (diluted)
$0.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
SANM
SANM
Q1 26
$1.9B
Q4 25
$1.6B
$3.2B
Q3 25
$1.5B
$2.1B
Q2 25
$1.7B
$2.0B
Q1 25
$1.6B
$2.0B
Q4 24
$1.5B
$2.0B
Q3 24
$1.6B
$2.0B
Q2 24
$1.5B
$1.8B
Net Profit
CME
CME
SANM
SANM
Q1 26
$1.2M
Q4 25
$1.2B
$49.3M
Q3 25
$908.0M
$48.1M
Q2 25
$1.0B
$68.6M
Q1 25
$956.2M
$64.2M
Q4 24
$874.6M
$65.0M
Q3 24
$912.8M
$61.4M
Q2 24
$883.2M
$51.6M
Gross Margin
CME
CME
SANM
SANM
Q1 26
Q4 25
7.6%
Q3 25
9.1%
Q2 25
8.9%
Q1 25
8.9%
Q4 24
8.4%
Q3 24
8.5%
Q2 24
8.3%
Operating Margin
CME
CME
SANM
SANM
Q1 26
0.1%
Q4 25
61.8%
2.3%
Q3 25
63.3%
3.7%
Q2 25
66.7%
4.7%
Q1 25
67.5%
4.6%
Q4 24
62.1%
4.4%
Q3 24
64.6%
4.4%
Q2 24
65.3%
4.5%
Net Margin
CME
CME
SANM
SANM
Q1 26
0.1%
Q4 25
71.7%
1.5%
Q3 25
59.1%
2.3%
Q2 25
60.6%
3.4%
Q1 25
58.2%
3.2%
Q4 24
57.3%
3.2%
Q3 24
57.6%
3.0%
Q2 24
57.6%
2.8%
EPS (diluted)
CME
CME
SANM
SANM
Q1 26
Q4 25
$3.24
$0.89
Q3 25
$2.49
$0.88
Q2 25
$2.81
$1.26
Q1 25
$2.62
$1.16
Q4 24
$2.40
$1.16
Q3 24
$2.50
$1.09
Q2 24
$2.42
$0.91

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
SANM
SANM
Cash + ST InvestmentsLiquidity on hand
$2.4B
$1.4B
Total DebtLower is stronger
$3.4B
$2.2B
Stockholders' EquityBook value
$2.7B
Total Assets
$202.0B
$9.8B
Debt / EquityLower = less leverage
0.82×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
SANM
SANM
Q1 26
$2.4B
Q4 25
$4.5B
$1.4B
Q3 25
$2.6B
$926.3M
Q2 25
$2.1B
$797.9M
Q1 25
$1.5B
$647.1M
Q4 24
$3.0B
$642.4M
Q3 24
$2.4B
$625.9M
Q2 24
$1.9B
$657.7M
Total Debt
CME
CME
SANM
SANM
Q1 26
$3.4B
Q4 25
$2.2B
Q3 25
$300.5M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
SANM
SANM
Q1 26
Q4 25
$28.7B
$2.7B
Q3 25
$28.2B
$2.5B
Q2 25
$27.7B
$2.5B
Q1 25
$27.0B
$2.4B
Q4 24
$26.5B
$2.4B
Q3 24
$28.2B
$2.4B
Q2 24
$27.6B
$2.3B
Total Assets
CME
CME
SANM
SANM
Q1 26
$202.0B
Q4 25
$198.4B
$9.8B
Q3 25
$187.1B
$5.9B
Q2 25
$179.9B
$5.2B
Q1 25
$157.8B
$5.0B
Q4 24
$137.4B
$4.8B
Q3 24
$137.8B
$4.8B
Q2 24
$123.4B
$4.7B
Debt / Equity
CME
CME
SANM
SANM
Q1 26
Q4 25
0.82×
Q3 25
0.12×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
SANM
SANM
Operating Cash FlowLast quarter
$178.7M
Free Cash FlowOCF − Capex
$91.9M
FCF MarginFCF / Revenue
2.9%
Capex IntensityCapex / Revenue
2.7%
Cash ConversionOCF / Net Profit
3.63×
TTM Free Cash FlowTrailing 4 quarters
$518.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
SANM
SANM
Q1 26
Q4 25
$1.1B
$178.7M
Q3 25
$968.1M
$199.1M
Q2 25
$1.1B
$200.8M
Q1 25
$1.1B
$156.9M
Q4 24
$1.0B
$63.9M
Q3 24
$1.0B
$51.9M
Q2 24
$776.9M
$90.0M
Free Cash Flow
CME
CME
SANM
SANM
Q1 26
Q4 25
$1.1B
$91.9M
Q3 25
$949.7M
$136.6M
Q2 25
$1.0B
$163.7M
Q1 25
$1.1B
$126.1M
Q4 24
$991.7M
$46.9M
Q3 24
$973.2M
$27.2M
Q2 24
$758.7M
$67.2M
FCF Margin
CME
CME
SANM
SANM
Q1 26
Q4 25
66.8%
2.9%
Q3 25
61.8%
6.5%
Q2 25
61.5%
8.0%
Q1 25
67.1%
6.4%
Q4 24
65.0%
2.3%
Q3 24
61.4%
1.4%
Q2 24
49.5%
3.7%
Capex Intensity
CME
CME
SANM
SANM
Q1 26
Q4 25
2.0%
2.7%
Q3 25
1.2%
3.0%
Q2 25
1.1%
1.8%
Q1 25
0.9%
1.5%
Q4 24
1.7%
0.9%
Q3 24
1.9%
1.2%
Q2 24
1.2%
1.2%
Cash Conversion
CME
CME
SANM
SANM
Q1 26
Q4 25
0.96×
3.63×
Q3 25
1.07×
4.14×
Q2 25
1.03×
2.93×
Q1 25
1.17×
2.44×
Q4 24
1.16×
0.98×
Q3 24
1.10×
0.85×
Q2 24
0.88×
1.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

SANM
SANM

Industrial And Energy Medical Defense And Aerospace And Automotive And Transportation$1.2B38%
ZT Systems$1.1B34%
Other Segments CPS$434.3M14%
CPS Third Party Revenue$412.7M13%
Change In Accounting Method Accounted For As Change In Estimate$2.7M0%

Related Comparisons